Only older or immunocompromised people who are naive to pneumococcal conjugate vaccines may get one of the newly licensed formulations under ACIP's current recommendations. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
